Dexamethasone nanowafer as an effective therapy for dry eye disease

Journal of Controlled Release

Volumn 213, Issue , 2015, Pages 168-174

  Coursey, Terry G ^a   Henriksson, Johanna Tukler ^a   Marcano, Daniela C ^a   Shin, Crystal S ^a   Isenhart, Lucas C ^a   Ahmed, Faheem ^a   De Paiva, Cintia S ^a   Pflugfelder, Stephen C ^a   Acharya, Ghanashyam ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cornea; Dexamethasone; Drug delivery; Dry eye; Inflammation; Nanowafer

Indexed keywords

DISEASE CONTROL; DROPS; DRUG DELIVERY; FILLED POLYMERS; MAMMALS; MEDICAL APPLICATIONS; MEDICAL PROBLEMS;

CORNEA; DEXAMETHASONES; DRY EYE; INFLAMMATION; NANOWAFER;

DRUG PRODUCTS;

CARBOXYMETHYLCELLULOSE; DEXAMETHASONE; EYE DROPS; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; NANOPARTICLE; NANOWAFER; POLYMER; RANTES; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYTOKINE; DELAYED RELEASE FORMULATION; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORNEA EPITHELIUM; DOSAGE SCHEDULE COMPARISON; DOWN REGULATION; DRUG EFFICACY; DRY EYE; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CHEMISTRY; CORNEA; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRY EYE SYNDROMES; IMMUNOLOGY; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBOXYMETHYLCELLULOSE SODIUM; CORNEA; CYTOKINES; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRY EYE SYNDROMES; FEMALE; MICE, INBRED C57BL; NANOSTRUCTURES;

EID: 84937552222     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.07.007     Document Type: Article

References (51)

1. M.A. Lemp, B.D. Sullivan, and L.A. Crews Biomarkers in dry eye disease Eur. Ophthalmic Rev. 6 2012 157 163
2. A. Tomlinson Epidemiology of dry eye disease P.A. Asbell, M.A. Lemp, Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment 2006 Thieme Medical Publishers, Inc. New York 1 15
3. J.L. Gayton Etiology, prevalence, and treatment of dry eye disease Clin. Ophthalmol. 3 2009 405 412
4. R. Latkany Dry eyes: etiology and management Curr. Opin. Ophthalmol. 19 2008 287 291
5. P.D. O'Brien, and L.M. Collum Dry eye: diagnosis and current treatment strategies Curr. Allergy Asthma Rep. 4 2004 314 319
6. D.A. Schaumberg, D.A. Sullivan, J.E. Buring, and M.R. Dana Prevalence of dry eye syndrome among US women Am J. Ophthalmol. 136 2003 318 326
7. M.A. Lemp Advances in understanding and managing dry eye disease Am J. Ophthalmol. 146 2008 350 356
8. The epidemiology of dry eye disease. Report of the epidemiology subcommittee of the international dry eye work shop Ocul. Surf. 5 2007 93 107
9. A.J. Bron Diagnosis of dry eye Surv. Ophthalmol. 45 Suppl. 2 2001 S221 S226
10. M. Uchino, Y. Uchino, M. Dogru, M. Kawashima, N. Yokoi, A. Komuro, Y. Sonomura, H. Kato, S. Kinoshita, D.A. Schaumberg, and K. Tsubota Dry eye disease and work productivity loss in visual display users: the Osaka study Am J. Ophthalmol. 157 2014 294 300
11. S.C. Pflugfelder, M.E. Stern, and R. Beuerman The problem S.C. Pflugfelder, M.E. Stern, R. Beuerman, Dry Eye and the Ocular Surface 2004 Marcel Dekker New York 1 10
12. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye work shop Ocul. Surf. 5 2007 75 92
13. P.A. Simmons, and J.G. Vehige Clinical performance of a mid-viscosity artificial tear for dry eye treatment Cornea 26 2007 294 302
14. D. Schmidl, L. Schmetterer, K.J. Witkowska, A. Unterhuber, V. Aranha Dos Santos, S. Kaya, J. Nepp, C. Baar, P. Rosner, R.M. Werkmeister, and G. Garhofer Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease Cornea 34 2015 421 426
15. S.C. Pflugfelder Anti-inflammatory therapy of dry eye Am J. Ophthalmol. 137 2004 337 342
16. A.M. Avunduk, M.C. Avunduk, E.D. Varnell, and H.E. Kaufman The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study Am J. Ophthalmol. 136 2003 593 602
17. N. Kara, H. Altinkaynak, Y. Goker, K. Yuksel, and Y. Yildirim Evaluation of corneal morphologic and functional parameters after use of topical cyclosporine-a 0.05% in dry eye J. Ocul. Pharmacol. Ther. 28 2012 593 597
18. C. Baudouin Side effects of antiglaucomatous drugs on the ocular surface Curr. Opin. Ophthalmol. 7 1996 80 86
19. M.K. Arici, D.S. Arici, A. Topalkara, and C. Guler Adverse effects of topical antiglaucoma drugs on the ocular surface Clin. Exp. Ophthalmol. 28 2000 113 117
20. Y.C. Kim, B. Chiang, X. Wu, and M.R. Prausnitz Ocular delivery of macromolecules J. Control. Release 190 2014 172 181
21. P. Aksungur, M. Demirbilek, E.B. Denkbas, J. Vandervoort, A. Ludwig, and N. Unlu Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies J. Control. Release 151 2011 286 294
22. M. Shah, M.C. Edman, S.R. Janga, P. Shi, J. Dhandhukia, S. Liu, S.G. Louie, K. Rodgers, J.A. Mackay, and S.F. Hamm-Alvarez A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome J. Control. Release 171 2013 269 279
23. Y. Diebold, and M. Calonge Applications of nanoparticles in ophthalmology Prog. Retin. Eye Res. 29 2010 596 609
24. Y.B. Choy, J.H. Park, B.E. McCarey, H.F. Edelhauser, and M.R. Prausnitz Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time Invest. Ophthalmol. Vis. Sci. 49 2008 4808 4815
25. I.M. Carvalho, C.S. Marques, R.S. Oliveira, P.B. Coelho, P.C. Costa, and D.C. Ferreira Sustained drug release by contact lenses for glaucoma treatment - a review J. Control. Release 202 2015 76 82
26. K. Singh, A.B. Nair, A. Kumar, and R. Kumria Novel approaches in formulation and drug delivery using contact lenses J. Basic Clin. Pharm. 2 2011 87 101
27. R. Garhwal, S.F. Shady, E.J. Ellis, J.Y. Ellis, C.D. Leahy, S.P. McCarthy, K.S. Crawford, and P. Gaines Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials Invest. Ophthalmol. Vis. Sci. 53 2012 1341 1352
28. M. Moshirfar, K. Pierson, K. Hanamaikai, L. Santiago-Caban, V. Muthappan, and S.F. Passi Artificial tears potpourri: a literature review Clin. Ophthalmol. 8 2014 1419 1433
29. A. Ludwig Mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 2005 1595 1639
30. Q. Garrett, P.A. Simmons, S. Xu, J. Vehige, Z. Zhao, K. Ehrmann, and M. Willcox Carboxy methyl cellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing Invest. Ophthalmol. Vis. Sci. 48 2007 1559 1567
31. T.J. Nagelhout, D.A. Gamache, L. Roberts, M.T. Brady, and J.M. Yanni Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye J. Ocul. Pharmacol. Ther. 21 2005 139 148
32. A.R. Djalilian, C.N. Nagineni, S.P. Mahesh, J.A. Smith, R.B. Nussenblatt, and J.J. Hooks Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin Cornea 25 2006 709 714
33. M.A. Patane, A. Cohen, S. From, G. Torkildsen, D. Welch, and G.W. Ousler III Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial Clin. Ophthalmol. 5 2011 633 643
34. X. Yuan, D.C. Marcano, C.S. Shin, X. Hua, L.C. Isenhart, S.C. Pflugfelder, and G. Acharya Ocular drug delivery nanowafer with enhanced therapeutic efficacy ACS Nano 9 2015 1749 1758
35. G. Acharya, C.S. Shin, K. Vedantham, M. McDermott, T. Rish, K. Hansen, Y. Fu, and K. Park A study of drug release from homogeneous PLGA microstructures J. Control. Release 146 2010 201 206
36. G. Acharya, C.S. Shin, M. McDermott, H. Mishra, H. Park, I.C. Kwon, and K. Park The hydrogel template method for fabrication of homogeneous nano/microparticles J. Control. Release 141 2010 314 319
37. D. Dursun, M. Wang, D. Monroy, D.Q. Li, B.L. Lokeshwar, M.E. Stern, and S.C. Pflugfelder A mouse model of keratoconjunctivitis sicca Invest. Ophthalmol. Vis. Sci. 43 2002 632 638
38. C.S. De Paiva, R.M. Corrales, A.L. Villarreal, W. Farley, D.-Q. Li, M.E. Stern, and S.C. Pflugfelder Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline Invest. Ophthalmol. Vis. Sci. 47 2006 2847 2856
39. R.M. Corrales, M.E. Stern, C.S. De Paiva, J. Welch, D.-Q. Li, and S.C. Pflugfelder Dessicating stress stimulates expression of matrix metalloproteinase by the corneal epithelium Invest. Ophthalmol. Vis. Sci. 47 2006 3293 3302
40. C.S. De Paiva, S.B. Pangelinan, E. Chang, K.-C. Yoon, W.J. Farley, D.-Q. Li, and S.C. Pflugfelder Essential role for c-Jun N-terminal kinase 2 in corneal epithelial response to desiccating stress Arch. Ophthalmol. 127 2009 1625 1631
41. R.M. Corrales, M.E. Stern, C.S. de Paiva, J. Welch, D.Q. Li, and S.C. Pflugfelder Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium Invest. Ophthalmol. Vis. Sci. 47 2006 3293 3302
42. K. Yoon, C.S. Park, I.C. You, H.J. Choi, K.H. Lee, S.K. Im, H.Y. Park, and S.C. Pflugfelder Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome Invest. Ophthalmol. Vis. Sci. 51 2010 643 650
43. D.T. Jones, D. Monroy, Z. Ji, S.S. Atherton, and S.C. Pflugfelder Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium Invest. Ophthalmol. Vis. Sci. 35 1994 3493 3504
44. S.C. Pflugfelder, D. Jones, Z. Ji, A. Afonso, and D. Monroy Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca Curr. Eye Res. 19 1999 201 211
45. X. Zhang, W. Chen, C.S. de Paiva, R.M. Corrales, E.A. Volpe, A.J. McClellan, W.J. Farley, D.Q. Li, and S.C. Pflugfelder Interferon-γ exacerbates dry eye induced apoptosis in conjunctiva via dual apoptotic pathways Invest. Ophthalmol. Vis. Sci. 52 2011 6279 6285
46. X. Zhang, C.S. de Paiva, Z. Su, E.A. Volpe, D.Q. Li, and S.C. Pflugfelder Topical interferon-γ neutralization prevents conjunctival goblet cell loss in experimental murine dry eye Exp. Eye Res. 118 2014 117 124
47. C.S. de Paiva, A.L. Villarreal, R.M. Corrales, H.T. Rahman, V.Y. Chang, J.W. Farley, M.E. Stern, J.Y. Niederkorn, D.Q. Li, and S.C. Pflugfelder IFN-γ promotes goblet cell loss in response to desiccating ocular stress Invest. Ophthalmol. Vis. Sci. 47 2006 (E-Abstract 5579)
48. C.S. de Paiva, A.L. Villarreal, R.M. Corrales, H.T. Rahman, V.Y. Chang, W.J. Farley, M.E. Stern, J.Y. Niederkorn, D.Q. Li, and S.C. Pflugfelder Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ Invest. Ophthalmol. Vis. Sci. 48 2007 2553 2560
49. L. Sobrin, Z. Liu, D.C. Monroy, A. Solomon, M.G. Selzer, B.L. Lokeshwar, and S.C. Pflugfelder Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant Invest. Ophthalmol. Vis. Sci. 41 2000 1703 1709
50. S.C. Pflugfelder, W. Farley, L. Luo, L.Z. Chen, C.S. de Paiva, L.C. Olmos, D.Q. Li, and M.E. Fini Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye Am. J. Pathol. 166 2005 61 71
51. C.S. de Paiva, R.M. Corrales, A.L. Villarreal, W.J. Farley, D.Q. Li, M.E. Stern, and S.C. Pflugfelder Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye Exp. Eye Res. 83 2006 526 535